Showing results (1-10 of 59) with videos related to
Sort By:
Pageof 6
Oxidative Medicine and Cellular Longevity|July 21, 2022
HIF1<i>α</i>: A Novel Biomarker with Potential Prognostic and Immunotherapy in Pan-cancerYonggang Tian, Feihu Bai, Dekui ZhangBiochimica Et Biophysica Acta. Reviews on Cancer|November 10, 2022
New target DDR1: A "double-edged sword" in solid tumorsYonggang Tian, Feihu Bai, Dekui ZhangFrontiers in Immunology|November 19, 2024
Gut microbiome and metabolomics in systemic sclerosis: feature, link and mechanismsQicen Yao, Wenfeng Tan, Feihu BaiFrontiers in Nutrition|August 20, 2024
Bidirectional relationship between <i>Helicobacter pylori</i> infection and nonalcoholic fatty liver disease: insights from a comprehensive meta-analysisDaya Zhang, Qi Wang, Feihu BaiInternational Journal of General Medicine|August 29, 2023
Roles of Gut Microbiota in Alcoholic Liver DiseaseDaya Zhang, ZhengJin Liu, Feihu BaiJournal of Gastrointestinal Cancer|January 20, 2026
A Bibliometric Analysis of Research Trends and Collaborative Networks in Gastric Cancer and Helicobacter Pylori StudiesYi Yu, Feihu Bai, Dekui Zhang, et al.Journal of Gastrointestinal Cancer|March 1, 2024
Biological Clock Genes are Crucial and Promising Biomarkers for the Therapeutic Targets and Prognostic Assessment in Gastric CancerYonggang Tian, Yunqian Xie, Feihu Bai, et al.Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy|May 4, 2023
Prevalence and Risk Factors of Metabolic-Associated Fatty Liver Disease Among Hospital StaffDaya Zhang, Lijun Zhang, Shiju Chen, et al.Cancer Management and Research|February 22, 2019
Attenuated ZHX3 expression serves as a potential biomarker that predicts poor clinical outcomes in breast cancer patientsYanjie You, Yuhong Ma, Qiang Wang, et al.Medicine|January 24, 2025
Microbiome characterization of patients with Crohn disease and the use of fecal microbiota transplantation: A reviewShiju Chen, Daya Zhang, Da Li, et al.Pageof 6